Moderna said it expects its updated vaccine to be available in the “coming days.” This approval ... vaccination status. If ...

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering ...

The FDA is looking to quickly approve Moderna’s COVID-19 vaccine after it was unanimously backed by a panel of experts. Yesterday’s advisory panel meeting voted 20-0 in favour of approving ...

A second coronavirus vaccine is nearing emergency approval in ... head of the Food and Drug Administration (FDA) said his agency would move quickly to authorise the Moderna vaccine, allowing ...

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax COVID-19 shot have slumped.

Drug developers Moderna Thursday filed for clearance from the US Food and Drug Administration (FDA) to extend the use of their COVID-19 vaccine to children aged 6 months to 5 years, it was announced.

Vaccines typically take multiple years to develop. But when it comes to the rapidly escalating coronavirus pandemic, drug ... are no approved mRNA vaccines on the market, Dunn said, so Moderna's ...

It was later granted full FDA approval in August 2021 for people ages 16 and older. Pfizer’s and Moderna's vaccine has been updated over time to target currently circulating variants ...

Before investing in a vaccine stock, find out about the status of the ... based therapeutics. Moderna (MRNA 7.48%) quickly followed Pfizer and BioNTech in winning U.S. approval for its COVID ...